HOME >> BIOLOGY >> NEWS
Dose of PTEN protein found to determine progression of prostate cancer

NEW YORK, NY October 27 - In patients with prostate cancer, one change that can be seen at the molecular level is the loss of the PTEN tumor suppressor gene, a gene responsible for restricting cell proliferation. One or both copies of the PTEN gene are found to have been lost in 70 percent of prostate cancer patients at the time of diagnosis. It has generally been believed that one remaining copy would still protect against tumor progression to advanced metastatic cancer.

But now, for the first time, scientists at Memorial Sloan-Kettering Cancer Center have established mouse models for prostate cancer that have varying "doses" or amounts of Pten protein produced from the remaining gene. Their results show that the activity of the single Pten gene does not necessarily protect against prostate cancer. Instead, the dose determines whether the tumor will become either an aggressive cancer or take a slow path towards microscopic features of growth, but remain benign. This new understanding of the natural history of the disease could allow researchers to develop novel clinical strategies to diagnose, treat, and possibly prevent prostate cancer. This article will appear both as HTML and in print in the December 23, 2003 issue of the new, open access journal published by the Public Library of Science. It appears in PDF form online as a pre-issue publication on October 27, 2003 at www.plosbiology.org.

"We have shown that prostate cancer development is not just affected by mutation and loss of the PTEN gene but that its progression is dose-dependent on the PTEN protein, which we have measured for the first time," said Pier Paolo Pandolfi, M.D., Ph.D., Head of the Molecular and Developmental Biology Laboratory at Memorial Sloan-Kettering and the study's senior author. "Two men, each with one PTEN gene left, could have totally different disease outcomes depending on the actual dose of PTEN protein coming from that ge
'"/>

Contact: Joanne Nicholas
mediastaff@mskcc.org
212-639-3573
Memorial Sloan-Kettering Cancer Center
27-Oct-2003


Page: 1 2 3

Related biology news :

1. New molecular link key to cellular proteins involved in cancer progression, other diseases
2. Researchers identify protein promoting vascular tumor growth
3. UCI scientists successfully target key HIV protein; breakthrough may lead to new drug therapies
4. Experimental drug shown to block mutant protein causing blood disease
5. Loss of the neuronal adhesion protein d-catenin leads to severe cognitive dysfunction
6. Images of tail of protein needed for cell multiplication suggest anticancer drug targets
7. New dye directly reveals activated proteins in living cells
8. Disruption of protein-folding causes neurodegeneration, mental retardation
9. A new protein is discovered to play a key role in cancer progression
10. Optimizing proteins death domain halts leukemia in laboratory study
11. Stuck on you: Scientists lay bare secrets of bacterial attachment proteins

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/16/2018)... ... November 16, 2018 , ... Bergeson & Campbell, P.C. (B&C®) ... will engage listeners in intelligent, insightful conversation about everything related to industrial, pesticidal, ... team of lawyers, scientists, and consultants will keep listeners abreast of the changing ...
(Date:11/15/2018)... ... ... Firmex today released new research on merger and acquisition advisory fees prepared in ... worldwide to compile the third annual M&A Fee Guide 2018-19 report. Contributors BDO ... , Highlights in the 2018-19 Report:, , The latest data ...
(Date:11/15/2018)... ... November 14, 2018 , ... ... lab, will present new scientific evidence on gene-disease relationships and how it supports ... to be held in Atlanta, November 14-17. , Ambry has been selected ...
Breaking Biology News(10 mins):
(Date:11/29/2018)... ... November 29, 2018 , ... RAGS, today announced the closing of ... Fund, with participation from existing investor and board member Jeremy Andrus, CEO of Traeger ... The additional funding will enable the company to accelerate its growth and expand the ...
(Date:11/20/2018)... VANCOUVER, British Columbia (PRWEB) , ... November 19, ... ... Repositories (ISBER) is pleased to announce the release of the Chinese translation of ... released in January 2018, is a practice-changing publication aimed at advancing the science ...
(Date:11/15/2018)... SAN FRANCISCO (PRWEB) , ... November 14, 2018 ... ... Indiegogo campaign, bringing the world’s first self-learning snore-reduction mask to the public. It ... to a poorer quality of sleep for themselves and their partner. The resulting ...
(Date:11/13/2018)... ... November 13, 2018 , ... Aditya Humad, Managing ... last week that asserts it is still trending upward with growing valuations based ... analysis describes market consolidation, pricing pressure and increased competition as reasons often cited ...
Breaking Biology Technology:
Cached News: